Perioperative medicine & outcomes

Preoperative activation of the renin–angiotensin system and myocardial injury in noncardiac surgery: exploratory mechanistic analysis of the SPACE randomised controlled trial

Br J AnaesthPublished Secondary analysis of the SPACE randomised controlled trial

Primary result · Myocardial injuryResult — go to the resultOdds ratio 1.95 95% CI 1.12–3.39

Authors' conclusion

This mechanistic exploratory analysis suggests that effective preoperative RAAS inhibition is associated with lower risk of myocardial injury after noncardiac surgery, independent of stopping or continuing RAAS inhibitors before surgery.

Study context

Population
Patients ≥60 yr undergoing elective noncardiac surgery, randomised to continue or stop renin-angiotensin-aldosterone system (RAAS) inhibitors
Participants
52 / 153 / 25
Comparison
RAAS activation clusters 1 and 3 vs cluster 2
  • Cluster 1n = 52
  • Cluster 2n = 153reference
  • Cluster 3n = 25
Primary endpoint
Myocardial injury (plasma high-sensitivity troponin-T)
Methodological detailsprespecified exploratory analysis, multicentre, unsupervised hierarchical cluster analysis, masked outcome
  • Prespecified exploratory analysis
  • Multicentre
  • Unsupervised hierarchical cluster analysis
  • Masked outcome

Primary result

Myocardial injury

Odds ratio

1.95

95% CI 1.12–3.39

P = 0.018

Events by treatment group

Clusters 1 and 3 vs Cluster 2
OR 1.95 (95% CI 1.12–3.39); P = 0.018

As reported in the abstract

Further findings

OutcomeMean difference (pg ml-1) (95% CI)
NT-proBNP concentrationClusters 1 and 3 vs Cluster 2698 (576–820)
Renin concentrationCluster 2 vs Clusters 1 and 3350 (123–577)

Original publication

Preoperative activation of the renin–angiotensin system and myocardial injury in noncardiac surgery: exploratory mechanistic analysis of the SPACE randomised controlled trial. Br J Anaesth. Published 20 December 2024. doi:10.1016/j.bja.2024.10.040

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.